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Abstract 
Hepatic epithelioid hemangioendothelioma (HEHE) is a rare neoplasm of vascular origin. 
The clinical presentation of HEHE is variable, and the therapeutic criteria are still unclear 
since its natural history is unpredictable. A 53-year-old woman was admitted to our 
hospital because she had a 2.5-cm diameter nodule in the segment V of the liver. She 
had undergone segmental hepatectomy for solitary HEHE in segment VII 10 years before. 
There had been no recurrence for the 10 years after the first operation. The tumor was 
diagnosed as a new lesion of HEHE by percutaneous needle liver biopsy, and thereafter 
repeated hepatectomy was performed. HEHE seems to be resistant to chemotherapy and 
radiotherapy. Either surgical resection or orthotopic liver transplantation is generally 
recommended as a curative treatment for this disease. However, HEHE tends to be 
detected in multiple lesions, and localized disease is rare. Therefore, the chance of 
resection is very low. Some reports do not recommend local resection because of early 
aggressive tumor spread even after curative resection. We herein demonstrate a rare 
case of HEHE in a patient who underwent repeated hepatectomy for a solitary lesion and 
who survived for 17 years. It is concluded that surgical resection is one of the most 
effective treatments for a solitary form of HEHE. 
 
Introduction 
Hepatic epithelioid hemangioendothelioma (HEHE) is a rare neoplasm of vascular 
origin with an unpredictable clinical course and prognosis. Epithelioid 
hemangioendothelioma (EHE) was first described by Weiss and Enzinger [1] in 1982. 
EHE usually occurs in soft tissues and bones, but rarely in the liver. HEHE is generally 
considered as a low-grade malignancy. Some cases were cured only by surgical resection 
while, in contrast, others were systemically metastatic and fatal disease at the time of  
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diagnosis [2, 3]. Due to the variability of the natural course, the therapeutic strategy 
remains to be determined. We herein report a patient who had two successful operations 
for a solitary lesion of HEHE and who survived for 17 years. 
Case Report 
The patient was an asymptomatic 53-year-old woman. She had been diagnosed with a hepatic 
neoplasm in 1991, but had refused to be operated on due to personal matters. However, she was willing 
to attend follow-up. During a follow-up period of three years, this hepatic tumor had grown from 2 to 
3 cm in diameter. In August 1994, she underwent segmental hepatectomy of segment VII. The tumor 
was histopathologically diagnosed as HEHE. After a follow-up period of 10 years after the first 
operation, in September 2004, routine ultrasonography revealed a well-defined and low-echoic nodule 
2.5 cm in diameter in the anterior segment of the liver. 
Laboratory data of liver function test were within normal range: aspartate aminotransferase, 18 IU/l; 
alanine aminotransferase, 17 IU/l; total bilirubin, 0.2 mg/dl; alkaline phosphatase, 135 IU/l; 
γ-glutamyl-transpeptitase, 13 IU/l; prothrombin activity, 105.7%. The data of tumor markers, such as 
carcinogenic embryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), alpha-fetoprotein and 
protein induced by vitamin K absence or antagonist (PIVKAII) was also within normal range. 
Computed tomography showed a solitary and low-density nodule in segment V of the liver. There 
were, however, no extrahepatic lesions in the lung, mediastinum, skin or soft tissue. The peripheral rim 
of the tumor, but not the center, was enhanced by contrast media in the early phase. Likewise, in the late 
phase, the intensity at the peripheral rim of the tumor was enhanced to a similar level as in the adjacent 
normal liver parenchyma, but again it did not change in the central part of the tumor (fig. 1a, b, c). 
T1-weighted axial magnetic resonance imaging showed a low signal intensity of the tumor, while a 
T2-weighted image showed a high signal. Celiac angiography showed a hypovascular tumor, but only 
the tumor margin was enhanced (fig. 1d). No extrahepatic neoplasm was detected on extensive 
examination, including colonoscopy and gastroscopy. 
Based on these findings, the tumor was suspected to be a new recurrent lesion of HEHE or 
cholangiocellular carcinoma. Immunohistochemical staining of the tumor tissue obtained using 
percutaneous ultrasonography-guided needle liver biopsy revealed that the tumor cells were positive for 
CD34 and factor VIII antigen, negative for CEA and CA19-9, and as a result the tumor was diagnosed as 
a recurrence of HEHE. 
The patient underwent subsegmental hepatectomy of segment V of the liver. The postoperative 
course was uneventful. A yellowish-white and non-encapsulated tumor approximately 2.5 cm in 
diameter and of rather hard consistency was macroscopically observed on the surface of the liver 
(fig. 2). Histopathological examination demonstrated that the cellular components were dominant in 
the peripheral region, while hyaline depositions were dominant in the central region. The tumor 
consisted of spindle-shaped cells and signet-ring-cell-like structures with intracytoplasmic lumina. 
Epithelioid cells were round in shape and had an eosinophilic cytoplasm and vesicular nuclei. 
Immunohistochemical staining revealed that epithelioid tumor cells were positive for CD34, factor VIII 
antigen and vimentin, and negative for CEA and CA19-9 (fig. 3). These findings were compatible with 
previous EHE reports. 
There has been no evidence of recurrent tumors for 4 years after the second hepatectomy. The 
patient has survived for 17 years after detection of the first HEHE. 
Discussion 
HEHE is a rare hepatic tumor of vascular origin [1–4]. EHE was classified as a 
malignant vascular tumor according to the 2002 WHO classification, but its natural 
course and prognosis are still unpredictable. Most HEHE patients are reported to present 
with nonspecific symptoms and are often asymptomatic with the tumor being detected 
coincidentally by imaging studies. Laboratory data are not usually useful for diagnosis of 
HEHE. Serum levels of tumor markers such as CEA, CA19-9 and alpha-fetoprotein  
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remain within normal limit. As the disease advances, however, clinical symptoms such as 
general malaise and abdominal discomfort appear, and laboratory data, including liver 
function test, may become worse [2, 3]. In this report, the patient was symptom-free and 
all laboratory data were within normal range. On ultrasonography, the echogenicity of the 
lesion was variable. The lesions most frequently show a hypoechogenic pattern compared 
with the adjacent liver parenchyma, and are occasionally isoechoic with a hypoechoic rim 
[5]. 
Among the imaging studies, computed tomography is the most sensitive imaging 
system for defining the extent of the tumor. Furui et al. [6] described two different types 
of HEHE, (1) nodular type and (2) diffuse type. They demonstrated that the nodular 
lesions were an earlier form of HEHE which later changed into diffuse lesions. The 
nodular type was observed in only 11.1% of patients at initial presentation, and 66% of 
cases had multiple lesions [2]. In the present case, however, the solitary lesion developed 
twice at the interval of 10 years, and the patient underwent two curative segmental 
hepatectomies for this solitary form of HEHE. HEHE most frequently shows a multifocal 
growth pattern at the time of diagnosis, therefore this kind of manifestation is very rare. 
Whether a solitary form is a temporary manifestation of multiple nodular form is still 
unknown, since very few reports regarding the solitary form of HEHE have been 
described previously. It might be an earlier stage of the multiple nodular form. 
Histological and immunohistochemical examinations are most useful for definitive 
diagnosis of HEHE. In immunohistochemical staining, the neoplastic cells are positive for 
factor VIII, CD31, and CD34, which are the endothelial cell makers [1–3]. In a recent 
study by Makhlouf et al. [3], core needle biopsy was performed in 22% of 137 cases. 
However, it should be noted that there is a risk of peritoneal seeding in image-guided core 
biopsy because of the usual location of HEHE at the periphery of the liver. Therefore, it is 
necessary to choose a transhepatic route of puncture through the normal hepatic 
parenchyma, not directly into the tumor, if feasible. 
As to conservative treatment, various kinds of therapy for patients with HEHE have 
been reported, but it is difficult to assess the effectiveness of each therapy and to decide on 
the therapeutic strategy for HEHE because of the rarity and unpredictable behavior of this 
neoplasm. The effectiveness of chemotherapy and radiotherapy is still not clear, but some 
authors have suggested that interferon α-2b is effective for HEHE [7]. In previously 
reported HEHE cases, there were several patients who remained alive for several years 
without any therapy [4]. Only one case report demonstrated spontaneous complete 
regression of HEHE without any treatment [8]. 
In contrast, surgical treatment such as curative liver resection and orthotopic liver 
transplantation (OLT) have frequently provided relatively satisfactory clinical results 
[2, 3, 9, 10]. In a recent study by Mehrabi et al. [11], they reported that the overall survival 
rate of patients who underwent liver resection was longer than that of patients 
undergoing OLT. Surgical resection for localized HEHE seems to be accepted as a 
standard therapeutic strategy. However, they also reported that only 9.4% of 286 patients 
underwent liver resection. Therefore, the curative resection rate for HEHE is still 
relatively low [10] because of the multicentric or multifocal occurrence of the tumor. 
Ben-Haim et al. described aggressive recurrence after curative surgical resection for 
resectable lesion by imaging series [12]. The authors suspected that during hepatic 
regeneration, some agent, such as hepatotrophic growth factor, stimulates HEHE 
proliferation [12]. However, the majority of those cases were the multiple form of HEHE, 
not the solitary form as in our case. The patient has not experienced early aggressive 
recurrence after two liver resections. Although there are no randomized control studies  
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on solitary or multiple lesion of HEHE because of its rarity, we consider that surgical 
resection may be a good option for patients with a solitary HEHE and no extrahepatic 
lesions. 
It has recently been reported that OLT has provided a good outcome for the diffuse 
type of HEHE. Some reports revealed that OLT was effective for HEHE even with 
extrahepatic localization of the disease [13]. Prognosis of HEHE is significantly better in 
comparison with that of other hepatic malignancies. However, less is known about truly 
long-term (more than 5 years) outcomes. As mentioned above, some patients were well 
for several years without any therapy. Interestingly, it appears that tumor spread has no 
influence on prognosis [2, 12–14]. 
In conclusion, we recommend hepatic resection for a solitary form of HEHE without 
extrahepatic lesions. For the multiple nodular type of HEHE without extrahepatic lesions, 
the indication of hepatic resection should be carefully determined, even if technically 
possible. In order to establish a therapeutic algorithm for HEHE, further studies and case 
series are necessary. 
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Fig. 1. Abdominal computed tomography findings showed a small low-density nodule with the rim 
enhanced in the early phase. a Plane. b Early phase. c Late phase. Celiac angiography showed a pale 
tumor stain with a relatively strong staining in the tumor margin (d). 
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Fig. 2. The resected specimen showed a yellowish-white tumor with a moderately hard 
consistency (a, b). 
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Fig. 3. Histopathological findings demonstrated that cellular components were dominant in the 
peripheral region, while hyaline deposits were dominant in the central region (a), and that the tumor 
consisted of spindle-shaped cells and signet-ring-cell-like structures with intracytoplasmic lumina (b). 
Immunohistochemical staining showed that tumor cells were positive for CD34 (c) and factor VIII (d). 
a H&E, ×20. b H&E, ×40. 
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